<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:32:43Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2568880" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2568880</identifier><datestamp>2008-10-16</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Genomics</journal-id>
      <journal-id journal-id-type="iso-abbrev">Genomics</journal-id>
      <journal-title-group>
        <journal-title>Genomics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0888-7543</issn>
      <issn pub-type="epub">1089-8646</issn>
      <publisher>
        <publisher-name>Academic Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC2568880</article-id>
      <article-id pub-id-type="pmcid">PMC2568880</article-id>
      <article-id pub-id-type="pmc-uid">2568880</article-id>
      <article-id pub-id-type="pmid">17629449</article-id>
      <article-id pub-id-type="publisher-id">S0888-7543(07)00118-8</article-id>
      <article-id pub-id-type="doi">10.1016/j.ygeno.2007.05.004</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Dissecting the human <italic>BDNF</italic> locus: Bidirectional transcription, complex splicing, and multiple promoters<sup><xref ref-type="fn" rid="d32e192">â</xref></sup></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Pruunsild</surname>
            <given-names>Priit</given-names>
          </name>
          <xref rid="fn1" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kazantseva<sup>1</sup></surname>
            <given-names>Anna</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aid</surname>
            <given-names>Tamara</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Palm</surname>
            <given-names>Kaia</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Timmusk</surname>
            <given-names>TÃµnis</given-names>
          </name>
          <email>tonis.timmusk@ttu.ee</email>
          <xref rid="cor1" ref-type="corresp">â</xref>
        </contrib>
      </contrib-group>
      <aff>Department of Gene Technology, Tallinn University of Technology, Akadeemia tee 15, Tallinn 19086, Estonia</aff>
      <author-notes>
        <corresp id="cor1"><label>â</label>Corresponding author. Fax: +372 620 4401. <email>tonis.timmusk@ttu.ee</email></corresp>
        <fn id="fn1">
          <label>1</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>1</day>
        <month>9</month>
        <year>2007</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2007</year>
      </pub-date>
      <volume>90</volume>
      <issue>3</issue>
      <fpage>397</fpage>
      <lpage>406</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>1</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>5</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2007 Elsevier Inc.</copyright-statement>
        <copyright-year>2007</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license xlink:href="https://creativecommons.org/licenses/by/3.0/">
          <license-p>Open Access under <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/3.0/">CC BY 3.0</ext-link> license</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Brain-derived neurotrophic factor (BDNF), a member of the nerve growth factor family of neurotrophins, has central roles in the development, physiology, and pathology of the nervous system. We have elucidated the structure of the human <italic>BDNF</italic> gene, identified alternative transcripts, and studied their expression in adult human tissues and brain regions. In addition, the transcription initiation sites for human <italic>BDNF</italic> transcripts were determined and the activities of <italic>BDNF</italic> promoters were analyzed in transient overexpression assays. Our results show that the human <italic>BDNF</italic> gene has 11 exons and nine functional promoters that are used tissue and brain-region specifically. Furthermore, noncoding natural antisense RNAs that display complex splicing and expression patterns are transcribed in the <italic>BDNF</italic> gene locus from the <italic>antiBDNF</italic> gene (approved gene symbol <italic>BDNFOS</italic>). We show that <italic>BDNF</italic> and <italic>antiBDNF</italic> transcripts form dsRNA duplexes in the brain in vivo, suggesting an important role for <italic>antiBDNF</italic> in regulating <italic>BDNF</italic> expression in human.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Neurotrophic factor</kwd>
        <kwd>Brain</kwd>
        <kwd>neuron</kwd>
        <kwd>Alternative splicing</kwd>
        <kwd>BDNF</kwd>
        <kwd>Natural antisense transcript</kwd>
        <kwd>RNA duplex</kwd>
        <kwd>Lin-7c/Mals-3/veli3</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Brain-derived neurotrophic factor (BDNF) is a member of the nerve growth factor family of neurotrophins. During development BDNF supports the survival and differentiation of selected neuronal populations of the peripheral and central nervous systems and participates in axonal growth and pathfinding and in the modulation of dendritic growth and morphology <xref rid="bib1 bib2" ref-type="bibr">[1,2]</xref>. BDNF also has a prominent role in later stages of nervous system development and in the adult by regulating synaptic transmission and plasticity and acts as a central modulator of pain <xref rid="bib3" ref-type="bibr">[3]</xref>. BDNF has been shown to be a modulator of synaptogenesis in vivo <xref rid="bib4" ref-type="bibr">[4]</xref> and has a functional role in the expression of LTP in the hippocampus <xref rid="bib5" ref-type="bibr">[5]</xref>. Data accumulated in recent years suggest that neuronal activity regulates transcription of <italic>BDNF,</italic> transport of <italic>BDNF</italic> mRNA and protein into dendrites, and secretion of BDNF protein, which are important for the formation of appropriate synaptic connections and for learning and memory during development and in adults <xref rid="bib6" ref-type="bibr">[6]</xref>. A single-nucleotide polymorphism in the human <italic>BDNF</italic> gene, resulting in a valine to methionine substitution (Val66Met) in the prodomain, has been shown to lead to reduced activity-induced BDNF secretion and memory impairment <xref rid="bib7" ref-type="bibr">[7]</xref>. BDNF signaling has been shown to be critical in several neuropsychiatric and neurodegenerative diseases <xref rid="bib1" ref-type="bibr">[1]</xref>, for example, Huntington disease <xref rid="bib8" ref-type="bibr">[8]</xref>. These results taken together show that BDNF has numerous important roles in brain development, physiology, and pathology.</p>
    <p>During development, BDNF protein expression is more abundant in the nervous system compared to other tissues and its levels are dramatically increased in the brain during postnatal development <xref rid="bib9" ref-type="bibr">[9]</xref>. In the adult nervous system, <italic>BDNF</italic> displays a widespread distribution pattern, with the highest levels of mRNA and protein in the hippocampus, amygdala, cerebral cortex, and hypothalamus <xref rid="bib9 bib10 bib11 bib12" ref-type="bibr">[9â12]</xref>. <italic>BDNF</italic> mRNA expression is mostly confined to neurons and there are only a few brain areas where <italic>BDNF</italic> mRNA is not detected <xref rid="bib10 bib11 bib12" ref-type="bibr">[10â12]</xref>. <italic>BDNF</italic> expression in adult tissues is detectable also outside of the central nervous system. Lower <italic>BDNF</italic> mRNA levels than in the hippocampus have been detected in the thymus, liver, spleen, heart, and lung <xref rid="bib9 bib11 bib13 bib14" ref-type="bibr">[9,11,13,14]</xref>.</p>
    <p>The structure and regulation of the <italic>BDNF</italic> gene have been studied in rodents <xref rid="bib15 bib16 bib17" ref-type="bibr">[15â17]</xref>. Mouse and rat <italic>BDNF</italic> genes have eight 5â² exons containing separate promoters upstream of each exon and one 3â² exon encoding the mature BDNF protein <xref rid="bib17" ref-type="bibr">[17]</xref>. Multiple promoters determine tissue-specific expression of the <italic>BDNF</italic> transcripts <xref rid="bib15 bib17" ref-type="bibr">[15,17]</xref>. The human <italic>BDNF</italic> has also been shown to consist of multiple 5â² noncoding exons and one coding exon, which give rise to alternatively spliced transcripts <xref rid="bib18 bib19 bib20" ref-type="bibr">[18â20]</xref>. According to the most recent description of the organization of the human <italic>BDNF</italic> gene locus and alternatively spliced transcripts the human <italic>BDNF</italic> has seven noncoding and one coding exon <xref rid="bib19" ref-type="bibr">[19]</xref>. Provided that only a partial description of the transcripts was given and expression of the alternative transcripts was studied in only a few brain regions and was not investigated in human nonneural tissues, we undertook the current study to analyze thoroughly the structure of the human <italic>BDNF</italic> gene, characterize the expression of alternatively spliced <italic>BDNF</italic> mRNAs in different human tissues and brain regions, and identify and study the activities of alternative human <italic>BDNF</italic> promoters.</p>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Structure and alternative splicing of human BDNF and antiBDNF (approved gene symbol BDNFOS)</title>
        <p>To reexamine the human <italic>BDNF</italic> gene structure and identify mRNAs transcribed from the gene, in silico analysis, 5â² rapid amplification of cDNA ends (5â² RACE), and RT-PCR analyses were performed. First, all <italic>BDNF</italic> mRNAs and expressed sequence tags (ESTs) available at the NCBI database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link>) were analyzed. Primers designed for PCR analyses are presented in <xref rid="app1" ref-type="sec">Supplementary Table 1</xref>. Total RNAs of the adult human frontal cerebral cortex, medulla, and hippocampus were used as templates in the RT-PCR. Second, to identify novel <italic>BDNF</italic> transcripts and to determine the transcription start sites for the human <italic>BDNF</italic> transcripts, 5â² RACE of human adult hippocampal and cerebellar RNA was performed using antisense primers specific for the 3â² exon and for the 5â² exons (<xref rid="app1" ref-type="sec">Supplementary Table 1</xref>).</p>
        <p><italic>BDNF</italic> gene exonâintron boundaries and genomic locations were determined by BLAT algorithm (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi%1Ebin/hgBlat">http://genome.ucsc.edu/cgi-bin/hgBlat</ext-link>) and by direct comparison of PCR-amplified sequences with genomic DNA sequence from the NCBI database (Accession No. <ext-link ext-link-type="gen" xlink:href="AF411339">AF411339</ext-link>). The designation of the human <italic>BDNF</italic> exons in this study is consistent with the naming of the mouse and rat <italic>BDNF</italic> exons described in the study by Aid et al. <xref rid="bib17" ref-type="bibr">[17]</xref>. The exons unique to human <italic>BDNF</italic> are marked with the letter âhâ and are named with the same number as the neighboring upstream exon. Our analysis showed that the human <italic>BDNF</italic> gene spans â¼Â 70Â kb and consists of 11 exons (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). <italic>hBDNF</italic> exons named by Liu et al. <xref rid="bib19" ref-type="bibr">[19]</xref> are designated here as old exons. Comparison of our data with that of Liu et al. <xref rid="bib19" ref-type="bibr">[19]</xref> shows that exons IâIV correspond to the respective old exons; exons V, Vh, VIII, and VIIIh are novel exons; exons VI and VII correspond to old exons V and VI, respectively; and exon IX variants IXb and IXd correspond to old exons VII and VIII, respectively (<xref rid="fig2" ref-type="fig">Fig. 2</xref>A). Nine of the exons, I, II, III, IV, V, Vh, VI, VII, and IX, can be defined as 5â² exons (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). Cloning and sequencing of the 5â² RACE products revealed that the transcription start sites relative to the 3â² end of the respective exon are located as follows: âÂ 647 and âÂ 428Â nt for exon I; âÂ 433, âÂ 423, âÂ 422, âÂ 416, âÂ 407, âÂ 400, âÂ 226, âÂ 224, âÂ 204, âÂ 200, âÂ 78, and âÂ 47Â nt for exon II; âÂ 237 and âÂ 191Â nt for exon III; âÂ 337, âÂ 333, âÂ 274, and âÂ 215Â nt for exon IV; âÂ 82, âÂ 80, and âÂ 79Â nt for exon V; âÂ 225 and âÂ 222Â nt for exon Vh; âÂ 324; âÂ 323, âÂ 319, âÂ 318, and âÂ 315Â nt for exon VI; and âÂ 184Â nt for exon VII (<xref rid="app1" ref-type="sec">Supplementary Fig. 1</xref>). We determined that human <italic>BDNF</italic> transcription starts also from the last exon, exon IX, âÂ 1102Â nt upstream of the translation start site in this exon (<xref rid="app1" ref-type="sec">Supplementary Fig. 1</xref>). No major differences in the transcription start site locations were observed when 5â² RACE products from hippocampal or cerebellar RNA were analyzed. Two exons, VIII and VIIIh, are rarely used and always in combination with exon V as the 5â² exon (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). Exons II, III, IV, V, Vh, VI, and VIIIh are untranslated exons and translation of the transcripts containing these exons starts from the ATG positioned in exon IX (<xref rid="app1" ref-type="sec">Supplementary Fig. 1</xref>). Exons I, VII, and VIII contain in-frame ATG codons that could be used as translation start sites leading to the prepro-BDNF proteins with longer N-termini (<xref rid="fig2" ref-type="fig">Fig. 2</xref>B).</p>
        <p>In addition, we identified alternative splice donor sites in exons II, V, and VI (<xref rid="fig1" ref-type="fig">Fig. 1</xref>, <xref rid="app1" ref-type="sec">Supplementary Fig. 1, and Table 2</xref>). Usage of these splice sites leads to the formation of transcripts with different 5â² UTR lengths but does not affect the coding region of <italic>BDNF.</italic> Characterization of the exonâintron boundary sequences showed that not all exonâintron splice junctions adhere to the GUâAG rule characteristic of eukaryotes. We found that exon VII is unique because the splice donor site used contains nucleotides GG instead of the conventional GU sequence (<xref rid="app1" ref-type="sec">Supplementary Table 2</xref>). Exon IX, which encodes the BDNF protein and 3â² UTR, is subjected to internal splicing and/or transcription initiation upstream of exon IX that leads to the generation of alternative transcripts containing variants of exon IX. These exon IX variants comprise different regions or combinations of regions of exon IX that were designated âaâ, âbâ, âcâ, and âdâ (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). Exon IX is used mostly in conjunction with the upstream exons (IâVIII, VIIIh), and in that case only the most 3â² region of exon IX, IXd, is included in the mature transcripts. On rare occasions when exon VI is the 5â² exon, alternative splicing occurs within exon IX leading to the inclusion of two regions, IXb and IXd, in the mRNAs. When transcription is initiated upstream of exon IX the transcripts are not subjected to internal splicing and contain all the regions of exon IX: IXa, IXb, IXc, and IXd. In extremely rare cases exon IX region âcâ is spliced out (<xref rid="fig1" ref-type="fig">Fig. 1</xref> and <xref rid="app1" ref-type="sec">Supplementary Fig. 1</xref>).</p>
        <p>Recently it was reported that natural antisense transcripts are transcribed from the human <italic>BDNF</italic> gene locus <xref rid="bib19" ref-type="bibr">[19]</xref>. We analyzed the exonâintron junctions of amplified <italic>BDNF</italic> cDNAs and also noticed that several mRNAs are transcribed in an antisense direction compared to BDNF mRNAs. This finding was also confirmed by orientation-specific RT-PCR and by RNase protection assay (data not shown). We named the gene and transcripts transcribed from the opposite strand of <italic>BDNF</italic> as <italic>antiBDNF</italic> (for antisense <italic>BDNF;</italic> part of it is described by Liu and colleagues and designated as OSBDNFâLiu et al. <xref rid="bib19" ref-type="bibr">[19]</xref>). The <italic>antiBDNF</italic> gene spans â¼Â 191Â kb and consists of at least 10 exons (exons 1â10) and is transcribed from one promoter as shown by our 5â² RACE analyses (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). All intronâexon boundaries of the <italic>antiBDNF</italic> gene are consistent with the GUâAG consensus (<xref rid="app1" ref-type="sec">Supplementary Table 2</xref>).</p>
        <p>Exons 1â4 of the <italic>antiBDNF</italic> gene are located downstream of the <italic>BDNF</italic> gene (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). Exon 5, 345Â bp in length, overlaps regions IXc and IXd and exon 6 overlaps region IXa of the <italic>BDNF</italic> coding exon. Exons 7â10 of <italic>antiBDNF</italic> are located in the introns of <italic>BDNF</italic>. In silico and RT-PCR analyses showed that alternative splicing from the <italic>antiBDNF</italic> pre-mRNA produces more than 300 transcripts, but exon 1 of <italic>antiBDNF</italic> is always used as the most 5â² exon for all the transcripts. Of note, our bioinformatics analysis showed that <italic>antiBDNF</italic> exon 1 is in head-to-head orientation with exon 1 of <italic>Lin-7c/Mals-3/veli3,</italic> suggesting that a bidirectional promoter controls the expression of these genes. The majority of the <italic>antiBDNF</italic> alternative transcripts contain exons 5 and 6, which are complementary to the <italic>BDNF</italic> protein-coding exon IX. However, in several <italic>antiBDNF</italic> transcripts exon 5 is skipped out. In addition, exon 5 of <italic>antiBDNF</italic> could be spliced using three alternative splice donor sites (<xref rid="fig1" ref-type="fig">Fig. 1</xref>, <xref rid="app1" ref-type="sec">Supplementary Fig. 2</xref>), and the lengths of exons 8 and 9 can vary because of usage of internal alternative splice acceptor sites (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). There are no potential open reading frames in any of the identified mRNAs transcribed from the <italic>antiBDNF</italic> gene, suggesting that these transcripts are non-protein-coding, as proposed also by Liu et al. <xref rid="bib19" ref-type="bibr">[19]</xref>.</p>
      </sec>
      <sec>
        <title>Expression of alternatively spliced BDNF and antiBDNF mRNAs in adult human tissues</title>
        <p>Expression of <italic>BDNF</italic> and <italic>antiBDNF</italic> transcripts was determined by RT-PCR in 22 different adult human tissues (<xref rid="fig3" ref-type="fig">Fig. 3</xref>). The results showed that human <italic>BDNF</italic> alternative transcripts are expressed in a tissue-specific manner. The levels of the majority of the human <italic>BDNF</italic> transcripts were highest in the brain. However, several alternative <italic>BDNF</italic> mRNAs showed relatively high expression levels in nonneural tissues. For example, expression levels of transcripts containing exons VI and IXabcd were high in the heart, placenta, and prostate. Transcripts containing exons I, Vh, VI, and IXabcd were highly expressed in the testis. High levels of transcripts containing exon VI were expressed also in the lung. Several <italic>BDNF</italic> mRNAs were expressed at moderate or low levels in the adrenal gland (exon Vh and exon IXabcd transcripts), bone marrow (exons I, VI, and IXabcd transcripts), kidney, muscle, stomach, spinal cord (exons Vh and VI transcripts), liver (exon IXabcd transcripts), small intestine (exon VI transcripts), and trachea (exons Vh, VI, and IXabcd transcripts). Low levels of exon IXabd transcripts were observed only in some cell lines (data not shown). <italic>BDNF</italic> mRNAs containing exons II and VII were expressed exclusively in the brain. Altogether, the results indicate that transcripts containing exons II, III, IV, V, and VII are predominantly brain-specific. Transcripts containing exons I and Vh are, in addition to brain, expressed in certain peripheral tissues, and transcripts containing exons VI and IXabcd show a wide pattern of expression.</p>
        <p><italic>antiBDNF</italic> transcripts were present at different levels in almost all human tissues analyzed (<xref rid="fig3" ref-type="fig">Fig. 3</xref>). High expression of human <italic>antiBDNF</italic> transcripts was detected in the brain, kidney, spinal cord, and testis. Moderate levels of <italic>antiBDNF</italic> RNA were seen in the lung, prostate, salivary gland, spleen, stomach, and uterus. Low <italic>antiBDNF</italic> expression levels were detected in the adrenal gland, liver, placenta, small intestine, and trachea. Certain alternative transcripts of <italic>antiBDNF</italic> were expressed in a tissue-specific manner. For example, <italic>antiBDNF</italic> transcripts with exon 10 were present in the colon and muscle, whereas transcripts with exon 9 were not expressed in these tissues. Taken together, <italic>BDNF</italic> and <italic>antiBDNF</italic> expression patterns were distinct, although partially overlapping.</p>
      </sec>
      <sec>
        <title>Expression of alternatively spliced BDNF and antiBDNF mRNAs in adult human brain regions</title>
        <p>Expression analysis of human <italic>BDNF</italic> and <italic>antiBDNF</italic> transcripts in 30 different adult brain regions was performed by RT-PCR (<xref rid="fig4" ref-type="fig">Fig. 4</xref>). Several differences in the expression of alternatively spliced human <italic>BDNF</italic> transcripts were detected. The results showed that all <italic>BDNF</italic> transcripts were expressed at high levels in the corpus mammillare (mammillary body), pons, hippocampus, frontal cortex, colliculi, and olfactory tract. All <italic>BDNF</italic> transcripts except the ones containing exons V and VII were expressed at high levels in the cerebellum and medulla, and all transcripts but those containing exon IXabcd were expressed at high levels in the infundibulum. <italic>BDNF</italic> expression in the dentate nucleus, white matter of the cerebellum, substantia nigra, nucleus ruber (red nucleus), and epiphysis was very low. <italic>BDNF</italic> expression was also very low in the globus pallidus, striatum (caudate nucleus and putamen), and thalamus, with the exception of exon IXabcd transcripts, which were expressed at relatively high levels in these regions. In the amygdala only transcripts containing exons I, IV, and VI were expressed at high levels. In the corpus callosum only exon VI and IXabcd transcripts were detected. Notably, comparison of expression levels of individual transcripts in different brain areas indicated that <italic>BDNF</italic> exon II transcript levels were much higher in the cerebellum than in other brain areas. Exon IXabcd mRNAs were expressed at relatively similar levels in all brain regions, with only infundibulum having very low expression levels. Interestingly, in the brain structures that contain only glial cells and axons and do not contain neuronal cell bodies, such as corpus callosum and optic nerve, exon IXabcd transcripts were predominantly detected. Transcripts containing exons I, Vh, and VI were also present in the optic nerve, although at low levels. <italic>antiBDNF</italic> transcripts were expressed in all studied brain structures at similar levels (<xref rid="fig4" ref-type="fig">Fig. 4</xref>).</p>
      </sec>
      <sec>
        <title>Promoter activities of the 5â² flanking regions of human BDNF and antiBDNF upstream exons</title>
        <p>Since the promoter regions of the human <italic>BDNF</italic> gene have not been analyzed previously and hypothesizing that a functional promoter precedes each of the identified 5â² exon of <italic>BDNF</italic> and that there is a promoter upstream of <italic>antiBDNF</italic> exon 1, the activities of nine potential promoter regions within the <italic>BDNF</italic> gene (namely the upstream sequences of exons I, II, III, IV, V, Vh, VI, VII, and IXabcd) and the region upstream of exon 1 of <italic>antiBDNF</italic> were analyzed for transcription-promoting activity using chloramphenicol acetyltransferase (CAT) assays. The putative promoter regions, each â¼Â 0.2â1.3Â kb in length and containing a part of the respective 5â² UTR and 5â² flanking genomic sequence (<xref rid="app1" ref-type="sec">Supplementary Fig. 1</xref>), were isolated and cloned into the pBLCAT2 vector in front of the <italic>CAT</italic> gene. The promoter constructs were transfected into human embryonic kidney HEK293T and mouse neuroblastoma N2a cells and the promoter activities were analyzed.</p>
        <p>The results showed that all the regions upstream of the 5â² exons of the <italic>BDNF</italic> gene and exon 1 of the <italic>antiBDNF</italic> gene were functional and could activate CAT expression (<xref rid="fig5" ref-type="fig">Fig. 5</xref>). Thus it was concluded that the regions upstream of the 5â² exons of the <italic>BDNF</italic> gene and exon 1 of the <italic>antiBDNF</italic> gene act as separate promoters. However, the activities of the promoters varied and differences were detected also between the cell lines used. The activities of promoters upstream of exons II, V, Vh, and VII were somewhat lower compared to other promoters in N2a cells. In HEK293T cells the activities of these promoters could be detected only after longer reaction times. Other promoters showed similar activities in both of the cell lines with <italic>BDNF</italic> promoters upstream of exons III and VI and the <italic>antiBDNF</italic> promoter being the strongest in both cell lines. However, promoters upstream <italic>BDNF</italic> exons I, IV, and IXabcd were slightly (about twofold) more active in HEK293T cells than in N2a cells.</p>
      </sec>
      <sec>
        <title>Human BDNF and antiBDNF transcripts form RNA duplexes in adult human brain in vivo</title>
        <p>According to our data human <italic>BDNF</italic> and <italic>antiBDNF</italic> are coexpressed in many tissues studied. The complementary region of the majority of spliced <italic>BDNF</italic> and <italic>antiBDNF</italic> transcripts spans 222Â nt or more depending on the splicing donor site used for <italic>antiBDNF</italic> exon 5 (<xref rid="app1" ref-type="sec">Supplementary Fig. 2 and Supplementary Table 2</xref>). Based on this knowledge we hypothesized that if <italic>antiBDNF</italic> has a regulatory role in <italic>BDNF</italic> expression, the complementary RNAs might form RNAâRNA duplexes in vivo. To study this hypothesis we performed a PCR-based assay. Briefly, RNase A/T1-treated RNA from adult human cerebellum was used as a potential double-stranded RNA (dsRNA) template for cDNA synthesis and the existence of the duplexes was analyzed by PCR with primers specific for the complementary region of <italic>BDNF</italic> and <italic>antiBDNF</italic> (<xref rid="app1" ref-type="sec">Supplementary Table 1</xref>). Our results showed that <italic>BDNF</italic>/<italic>antiBDNF</italic> dsRNA duplexes are present in the human brain in vivo (<xref rid="fig6" ref-type="fig">Fig. 6</xref>). Control experiments using a primer targeting the region of <italic>antiBDNF</italic> RNA outside of the complementary sequence in combination with a primer specific for the complementary region and experiments using RNA template in which the reverse transcription reaction was omitted showed that the RNA duplex-specific product was not the result of single-strand RNA (ssRNA) or genomic DNA contamination, respectively.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Previous studies have revealed that the human <italic>BDNF</italic> gene consists of seven putative 5â² exons and one protein-coding exon <xref rid="bib19 bib20" ref-type="bibr">[19,20]</xref>. However, the expression patterns of different exons have not been thoroughly studied and possible linkage of these exons to separate promoters has not been investigated. Here we show that the human <italic>BDNF</italic> gene, extending over 70Â kb, contains 11 exons. The 3â² exon encodes all or most of the protein depending on the 5â² exon used. Independent of the 5â² exon usage, two separate polyadenylation signals in exon IX can be utilized in <italic>BDNF</italic> transcripts. In addition, our data showed that the human <italic>BDNF</italic> gene comprises nine functional promoters.</p>
      <p>The structures of the human <italic>BDNF</italic> gene and transcripts determined in this study are in good agreement with the results obtained for the rat and mouse <italic>BDNF</italic> genes <xref rid="bib17" ref-type="bibr">[17]</xref>. Some differences are present, though. First, human <italic>BDNF</italic> contains two more exons than rodent <italic>BDNF.</italic> Compared to the rat and mouse genes <xref rid="bib17" ref-type="bibr">[17]</xref> there is an additional exon, exon Vh, linked to a promoter between exons V and VI. Human <italic>BDNF</italic> exon VIIIh, which is not linked to a separate promoter, is also not present in rodent <italic>BDNF.</italic> Furthermore, cryptic splicing donor and acceptor sites are used in human exon IX leading to transcripts containing exons IXbd and IXabd. These transcripts have not been detected in rodents <xref rid="bib17" ref-type="bibr">[17]</xref>. All this adds more complexity to the regulation of human <italic>BDNF.</italic> Second, in most cases, the usage of alternative promoters in the human <italic>BDNF</italic> gene leads to the expression of transcripts with different 5â² UTRs and with the protein-coding region in the common 3â² exon IXd. However, usage of an alternative upstream in-frame translation start site containing exon I, VII, or VIII could potentially lead to human BDNF prepro-proteins with longer N-termini. Only the translation initiation codon within exon I is characteristic of rodent <italic>BDNF</italic> genes, suggesting that there are more BDNF protein isoforms in human than in rodents. Third, although the transcription initiation sites are generally in good agreement with the respective regions in rodents, we identified more transcription start sites for human exons II and IV than had been reported previously for the rodent <italic>BDNF</italic> respective exons. Fourth, in contrast to the rodent <italic>BDNF</italic> genes we found that exon VIII of the human <italic>BDNF</italic> is not used as a 5â² exon as determined by the 5â² RACE analysis. We show that in human the rarely used exon VIII of <italic>BDNF</italic> is exclusively spliced to exon V. Exon V can also be spliced to exon IXd without including exon VIII. Exon VIII was not detected in any transcript other than the ones starting with exon V, pointing to a possible functional regulation between the usage of a certain promoter and subsequent splicing. Similar promoter-governed splicing regulation has been identified for the human nitric oxide synthase (<italic>NOS1</italic>) <xref rid="bib21" ref-type="bibr">[21]</xref> and mouse <italic>bcl-X</italic>
<xref rid="bib22" ref-type="bibr">[22]</xref> genes, for example. This kind of splicing regulation is especially interesting provided the notion that exon VIII of <italic>BDNF</italic> contains one of the alternative ATGs that may lead to the synthesis of a prepro-BDNF protein with an alternative N-terminus.</p>
      <p>We analyzed the splicing of the human <italic>BDNF</italic> pre-mRNAs and expression of consequent alternative mRNAs in detail. We found that <italic>BDNF</italic> transcripts containing exons II, III, IV, V, and VII are mostly brain-specific, whereas other <italic>BDNF</italic> mRNAs are also expressed at variable levels in nonneural tissues. Similar to the expression pattern of <italic>BDNF</italic> mRNAs in rodents <xref rid="bib16 bib17" ref-type="bibr">[16,17]</xref>, the most abundant transcripts in human nonneural tissues were transcripts containing exons VI and IXabcd that were expressed at high levels in several tissues, particularly heart, lung, skeletal muscle, testis, prostate, and placenta. To the best of our knowledge, these are the first data about the expression of alternatively spliced <italic>BDNF</italic> mRNAs in human nonneural tissues. In the human brain, expression of BDNF has been studied at the protein level using many different antibodies, the specificity of which is not always clear <xref rid="bib23" ref-type="bibr">[23]</xref>. Fewer data are available about <italic>BDNF</italic> mRNA expression. In most studies on human <italic>BDNF,</italic> mRNA expression has been studied in only some regions of brain using postmortem tissue <xref rid="bib23 bib24 bib25" ref-type="bibr">[23â25]</xref>. In two studies the expression of human <italic>BDNF</italic> mRNAs with alternative 5â² exons was examined in a few adult brain regions using RT-PCR <xref rid="bib19 bib26" ref-type="bibr">[19,26]</xref>. Our study is the first to examine <italic>BDNF</italic> exon-specific mRNA levels across the whole human brain, thus adding important new data to <italic>BDNF</italic> expression in adult human brain. In the adult human brain, high levels of <italic>BDNF</italic> mRNAs were present in the hippocampus, cerebral cortex, amygdala, and cerebellum, which is similar to the previously reported data on the <italic>BDNF</italic> expression in rodent brain <xref rid="bib10 bib11 bib15 bib27 bib28" ref-type="bibr">[10,11,15,27,28]</xref>. <italic>BDNF</italic> is expressed predominantly in neurons, although some studies have identified <italic>BDNF</italic> expression also in rodent astrocytes <xref rid="bib29 bib30" ref-type="bibr">[29,30]</xref>, microglia <xref rid="bib31" ref-type="bibr">[31]</xref>, and oligodendrocytes <xref rid="bib32" ref-type="bibr">[32]</xref>, both in vivo and in vitro. Here we show that some of the alternatively spliced human <italic>BDNF</italic> mRNAs, particularly transcripts containing exons VI and IXabcd, are present in vivo in the corpus callosum and optic nerve containing mostly oligodendroglial cells and axonal projections.</p>
      <p>Gene expression in eukaryotes is a highly coordinated process involving regulation at many different levels, among which the regulation of transcription is one of the most important. Several types of <italic>cis</italic>-acting DNA sequence elements, including promoters, contribute to this process. About 18% of human genes have multiple promoters, which regulate and increase their transcriptional and translational potential <xref rid="bib33" ref-type="bibr">[33]</xref>. Human <italic>BDNF</italic> promoter IV is the only promoter of the human <italic>BDNF</italic> gene that had been characterized so far <xref rid="bib18" ref-type="bibr">[18]</xref>. In this study we show that <italic>BDNF</italic> gene expression is under the control of at least nine alternative tissue-specific promoters linked to separate 5â² exons. Alternative promoters of the <italic>BDNF</italic> gene could also be involved in developmental stage-specific expression and cell-type-specific expression, giving additional flexibility to the control of <italic>BDNF</italic> expression. Therefore, the data presented in this study show that the expression of the human <italic>BDNF</italic> gene is highly regulated at the level of transcription.</p>
      <p>One of the results of our study was the characterization of endogenous noncoding antisense RNAs transcribed from the human <italic>BDNF</italic> gene locus. According to our data the <italic>antiBDNF</italic> gene consists of 10 exons and one functional promoter upstream of exon 1. We show that <italic>antiBDNF</italic> transcripts are expressed in almost all adult human tissues analyzed. High levels of <italic>antiBDNF</italic> mRNAs are present in the brain, kidney, spinal cord, and testis. Expression levels are low in adrenal gland, bone marrow, pancreas, small intestine, uterus, and some other tissues. In the adult brain, all <italic>antiBDNF</italic> transcripts are expressed at similar levels in all brain regions analyzed. We found that hundreds of different noncoding RNAs might be generated from the <italic>antiBDNF</italic> gene as a result of alternative splicing. Alternatively spliced isoform diversity is common to many eukaryotic organisms and it is particularly widely used in the nervous system <xref rid="bib34" ref-type="bibr">[34]</xref>. Interestingly, <italic>antiBDNF</italic> is not present in rodents <xref rid="bib16 bib17" ref-type="bibr">[16,17]</xref>. <italic>antiBDNF</italic> ESTs are also not available for chimpanzee and rhesus monkey although highly homologous sequences are present in the genomes of these animals (data not shown). All this suggests that <italic>antiBDNF</italic> could have evolved during primate/hominid evolution, as was proposed also by Liu et al. <xref rid="bib19" ref-type="bibr">[19]</xref>.</p>
      <p>In this study we have shown that in the human brain <italic>BDNF</italic> and <italic>antiBDNF</italic> transcripts form dsRNA duplexes in vivo. This indicates that <italic>antiBDNF</italic> transcripts could have an important role in the regulation of <italic>BDNF</italic> expression in human. Several studies have shown that natural antisense transcripts (NATs) are involved in the regulation of gene expression in eukaryotes <xref rid="bib35 bib36" ref-type="bibr">[35,36]</xref>. For example, NATs have been suggested to play an important role in the regulation of several genes encoding transcription factors that are important in eye development and function in mice <xref rid="bib37" ref-type="bibr">[37]</xref>. Characterization of overlapping transcripts in various species indicates that this form of RNA-mediated gene regulation represents a widespread phenomenon <xref rid="bib36 bib38" ref-type="bibr">[36,38]</xref>. NATs are particularly prevalent in the nervous system where they regulate the expression of several genes <xref rid="bib35" ref-type="bibr">[35]</xref>. In the case of human <italic>BDNF</italic> and <italic>antiBDNF,</italic> the transcripts could act as <italic>cis</italic>-antisense RNAs and generate siRNAs targeting one of the initial transcripts, as do the natural <italic>cis</italic>-siRNAs described for genes involved in salt tolerance in <italic>Arabidopsis thaliana</italic>
<xref rid="bib39" ref-type="bibr">[39]</xref>. Other possible regulatory functions of <italic>antiBDNF</italic> would be direct inhibition of <italic>BDNF</italic> transcription or translation and/or regulation of <italic>BDNF</italic> pre-mRNA splicing. Our results show that the expression of <italic>antiBDNF</italic> and <italic>BDNF</italic> transcripts in different tissues is not mutually exclusive and that the levels of <italic>BDNF</italic> mRNA do not appear to be specifically reduced in tissues that express high levels of <italic>antiBDNF</italic> transcripts. However, it is possible that the <italic>antiBDNF</italic> transcripts could modulate the levels of <italic>BDNF</italic> provided they are coexpressed in the same cell.</p>
      <p>In conclusion, this detailed characterization of the human <italic>BDNF</italic> gene locus opens up insights into the mechanisms governing <italic>BDNF</italic> gene regulation in human.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec>
        <title>RNA isolation, RT-PCR, and cloning and sequencing of RT-PCR products</title>
        <p>Total RNAs from 23 human tissues were obtained from Clontech. Total RNAs from postmortem adult human brain regions were isolated using the RNAwiz RNA isolation reagent and treated with DNase (Ambion, USA) according to the supplier's protocol. All experiments with human tissues were approved by the local ethical committee. Five micrograms of total RNA was reverse-transcribed to cDNA with an oligo(dT) primer (Proligo, France) and SuperScript III reverse transcriptase using the SuperScript III First-Strand Synthesis System (Invitrogen, USA). PCR amplification was carried out using HOT FIREPol DNA polymerase (Solis Biodyne, Estonia), according to the manufacturer's instructions. One-fortieth of the first-strand cDNA reaction mix was used in the PCR. The exon-specific PCR primers were designed based on the sequence of the human <italic>BDNF</italic> gene (NCBI Accession No. <ext-link ext-link-type="gen" xlink:href="AF411339">AF411339</ext-link>), ESTs, and mRNA sequences from GenBank. Sequences for all primers are listed in Table 1 of the supplementary material. The lengths of the PCR products using the primer hBDNF_IXbAS in combination with the following primers were hBDNF_IS, 472Â bp; hBDNF_IIS, 610, 527, and 312Â bp; hBDNF_IIIS, 347Â bp; hBDNF_IVS, 412Â bp; hBDNF_VS, 673, 556, and 273Â bp; hBDNF_VhS, 340Â bp; hBDNF_VIS, 494, 387, and 369Â bp; hBDNF_VIIS, 429 and 328Â bp; and hBDNF_IXS, 597 and 363Â bp. The lengths of the longest PCR products with haBDNF_1S in combination with the following primers were haBDNF_9AS, 947Â bp, and haBDNF_10AS, 1483Â bp. All products from the RT-PCR were cloned into the pCRII-TOPO vector (Invitrogen) and sequenced.</p>
      </sec>
      <sec>
        <title>Analyses of transcription start sites</title>
        <p>The transcription start sites for the <italic>BDNF</italic> and <italic>antiBDNF</italic> transcripts were detected with 5â² RACE using the GeneRacer Kit (Invitrogen) for full-length, RNA ligase-mediated rapid amplification of 5â² cDNA ends, according to the manufacturer's instructions. Briefly, 5Â Î¼g of total RNA from human hippocampus and cerebellum was dephosphorylated and decapped. The GeneRacer RNA oligo was ligated to the decapped 5â² ends of the full-length mRNAs and reverse transcription of the mRNAs was performed. RACE-ready cDNAs were used as templates for subsequent PCR using the GeneRacer 5â² primer in combination with <italic>BDNF</italic> exon-specific primers (<xref rid="app1" ref-type="sec">Supplementary Table 1</xref>). The PCR products were gel purified and cloned into the pCRII-TOPO (Invitrogen) vector and verified by sequencing.</p>
      </sec>
      <sec>
        <title>BDNF promoterâCAT reporter plasmids and CAT assay</title>
        <p>PCR was performed to amplify promoter fragments of the human <italic>BDNF</italic> and <italic>antiBDNF</italic> genes with the appropriate primers (<xref rid="app1" ref-type="sec">Supplementary Table 1</xref>). Human genomic DNA was used as a template. The amplified fragments were cloned into the pBL-CAT2 plasmid upstream of the coding region of the <italic>CAT</italic> gene, replacing the thymidine kinase promoter, and verified by sequencing. HEK293T and N2a cells were used for the analysis of promoter activities. The cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum at 37Â°C in a 5% CO<sub>2</sub> atmosphere. Transfection of cells with the promoterâCAT reporter plasmids was performed with FuGENE 6 (Roche Diagnostics, USA) according to the supplier's instructions. The transfected cells were harvested 40Â h after transfection. The samples were incubated with <sup>14</sup>C-labeled chloramphenicol and acetyl-CoA and the radioactive products were separated by thin-layer chromatography silica gel (Merck, USA) and visualized by autoradiography as described before <xref rid="bib15" ref-type="bibr">[15]</xref>.</p>
      </sec>
      <sec>
        <title>BDNF/antiBDNF RNA duplex analyses</title>
        <p>Ten micrograms of human cerebellar RNA, isolated with RNAwiz (Ambion), was treated with DNase (Ambion Turbo DNA-<italic>free</italic>) for 30Â min at 37Â°C according to the manufacturer's instructions, precipitated, and treated with RNase A/T1 (Ambion) for 30Â min at 37Â°C in RNase buffer (300Â mM NaCl, 10Â mM Tris, pH 7.4, and 5Â mM EDTA). The reaction was terminated with 0.4Â mg/ml proteinase K (Roche) in 200Â mM Tris, pH 7.4, 25Â mM EDTA, and 1% SDS for 30Â min at 37Â°C, and the dsRNA was phenol/chloroform extracted. cDNA was synthesized from this dsRNA using the <italic>BDNF/antiBDNF</italic> complementary region-specific primer Dup_S1 (<xref rid="app1" ref-type="sec">Supplementary Table 1</xref>) with Superscript III (Invitrogen) according to the manufacturer's instructions in the presence of 5% DMSO. In subsequent RNA duplex detection PCR 1/20 of the cDNA was used along with primers specific for the <italic>BDNF/antiBDNF</italic> complementary region, Dup_S1 and Dup_AS (<xref rid="app1" ref-type="sec">Supplementary Table 1</xref>; product size 156Â bp). Primer haBDNF_1S recognizing <italic>antiBDNF</italic> exon 1 in combination with Dup_S2 (<xref rid="app1" ref-type="sec">Supplementary Table 1</xref>; product size 490Â bp) was used for detection of ssRNA contamination. In addition, a âÂ RT reaction was used for detection of genomic DNA contamination using primers Dup_S1 and Dup_AS. All PCRs were performed as follows: 40Â cycles of 94Â°C for 30Â s, 57Â°C for 30Â s, and 72Â°C for 30Â s.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Binder</surname>
              <given-names>D.K.</given-names>
            </name>
            <name>
              <surname>Scharfman</surname>
              <given-names>H.E.</given-names>
            </name>
          </person-group>
          <article-title>Brain-derived neurotrophic factor</article-title>
          <source>Growth Factors</source>
          <volume>22</volume>
          <year>2004</year>
          <fpage>123</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="pmid">15518235</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bibel</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Barde</surname>
              <given-names>Y.A.</given-names>
            </name>
          </person-group>
          <article-title>Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system</article-title>
          <source>Genes Dev.</source>
          <volume>14</volume>
          <year>2000</year>
          <fpage>2919</fpage>
          <lpage>2937</lpage>
          <pub-id pub-id-type="pmid">11114882</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pezet</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>McMahon</surname>
              <given-names>S.B.</given-names>
            </name>
          </person-group>
          <article-title>Neurotrophins: mediators and modulators of pain</article-title>
          <source>Annu. Rev. Neurosci.</source>
          <volume>29</volume>
          <year>2006</year>
          <fpage>507</fpage>
          <lpage>538</lpage>
          <pub-id pub-id-type="pmid">16776595</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alsina</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Vu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Cohen-Cory</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Visualizing synapse formation in arborizing optic axons in vivo: dynamics and modulation by BDNF</article-title>
          <source>Nat. Neurosci.</source>
          <volume>4</volume>
          <year>2001</year>
          <fpage>1093</fpage>
          <lpage>1101</lpage>
          <pub-id pub-id-type="pmid">11593233</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Korte</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Brem</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Thoenen</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Bonhoeffer</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>92</volume>
          <year>1995</year>
          <fpage>8856</fpage>
          <lpage>8860</lpage>
          <pub-id pub-id-type="pmid">7568031</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>BDNF and activity-dependent synaptic modulation</article-title>
          <source>Learn. Mem.</source>
          <volume>10</volume>
          <year>2003</year>
          <fpage>86</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="pmid">12663747</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egan</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Callicott</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>T.E.</given-names>
            </name>
            <name>
              <surname>Kolachana</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Bertolino</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zaitsev</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Gold</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Goldman</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Dean</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Weinberger</surname>
              <given-names>D.R.</given-names>
            </name>
          </person-group>
          <article-title>The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function</article-title>
          <source>Cell</source>
          <volume>112</volume>
          <year>2003</year>
          <fpage>257</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="pmid">12553913</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zuccato</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cattaneo</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Role of brain-derived neurotrophic factor in Huntington's disease</article-title>
          <source>Prog. Neurobiol.</source>
          <year>2007</year>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katoh-Semba</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>I.K.</given-names>
            </name>
            <name>
              <surname>Semba</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain</article-title>
          <source>J. Neurochem.</source>
          <volume>69</volume>
          <year>1997</year>
          <fpage>34</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">9202291</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conner</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Lauterborn</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Gall</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Varon</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport</article-title>
          <source>J. Neurosci.</source>
          <volume>17</volume>
          <year>1997</year>
          <fpage>2295</fpage>
          <lpage>2313</lpage>
          <pub-id pub-id-type="pmid">9065491</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ernfors</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wetmore</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Persson</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family</article-title>
          <source>Neuron</source>
          <volume>5</volume>
          <year>1990</year>
          <fpage>511</fpage>
          <lpage>526</lpage>
          <pub-id pub-id-type="pmid">2206535</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Timmusk</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Persson</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Metsis</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Analysis of transcriptional initiation and translatability of brain-derived neurotrophic factor mRNAs in the rat brain</article-title>
          <source>Neurosci. Lett.</source>
          <volume>177</volume>
          <year>1994</year>
          <fpage>27</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">7824176</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maisonpierre</surname>
              <given-names>P.C.</given-names>
            </name>
            <name>
              <surname>Le Beau</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Espinosa</surname>
              <given-names>R.</given-names>
              <suffix>III</suffix>
            </name>
            <name>
              <surname>Ip</surname>
              <given-names>N.Y.</given-names>
            </name>
            <name>
              <surname>Belluscio</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>de la Monte</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Squinto</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Furth</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Yancopoulos</surname>
              <given-names>G.D.</given-names>
            </name>
          </person-group>
          <article-title>Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations</article-title>
          <source>Genomics</source>
          <volume>10</volume>
          <year>1991</year>
          <fpage>558</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="pmid">1889806</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maisonpierre</surname>
              <given-names>P.C.</given-names>
            </name>
            <name>
              <surname>Belluscio</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Alderson</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Wiegand</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Furth</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Lindsay</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Yancopoulos</surname>
              <given-names>G.D.</given-names>
            </name>
          </person-group>
          <article-title>NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression</article-title>
          <source>Neuron</source>
          <volume>5</volume>
          <year>1990</year>
          <fpage>501</fpage>
          <lpage>509</lpage>
          <pub-id pub-id-type="pmid">1688327</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Timmusk</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Palm</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Metsis</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Reintam</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Paalme</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Saarma</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Persson</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Multiple promoters direct tissue-specific expression of the rat BDNF gene</article-title>
          <source>Neuron</source>
          <volume>10</volume>
          <year>1993</year>
          <fpage>475</fpage>
          <lpage>489</lpage>
          <pub-id pub-id-type="pmid">8461137</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Q.R.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>X.G.</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Shaham</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Uhl</surname>
              <given-names>G.R.</given-names>
            </name>
          </person-group>
          <article-title>Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine</article-title>
          <source>Brain Res.</source>
          <volume>1067</volume>
          <year>2006</year>
          <fpage>1</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">16376315</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aid</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kazantseva</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Piirsoo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Palm</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Timmusk</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Mouse and rat BDNF gene structure and expression revisited</article-title>
          <source>J. Neurosci. Res.</source>
          <volume>85</volume>
          <year>2007</year>
          <fpage>525</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="pmid">17149751</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Chartier</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sodja</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Desbois</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ribecco-Lutkiewicz</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Sikorska</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Transcriptional activation of the human brain-derived neurotrophic factor gene promoter III by dopamine signaling in NT2/N neurons</article-title>
          <source>J. Biol. Chem.</source>
          <volume>278</volume>
          <year>2003</year>
          <fpage>26401</fpage>
          <lpage>26409</lpage>
          <pub-id pub-id-type="pmid">12738784</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Q.R.</given-names>
            </name>
            <name>
              <surname>Walther</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Drgon</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Polesskaya</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Lesnick</surname>
              <given-names>T.G.</given-names>
            </name>
            <name>
              <surname>Strain</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>de Andrade</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bower</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Maraganore</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Uhl</surname>
              <given-names>G.R.</given-names>
            </name>
          </person-group>
          <article-title>Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's disease</article-title>
          <source>Am. J. Med. Genet. B Neuropsychiatr. Genet.</source>
          <volume>134</volume>
          <year>2005</year>
          <fpage>93</fpage>
          <lpage>103</lpage>
          <pub-id pub-id-type="pmid">15666411</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aoyama</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Asai</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Shishikura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kawamoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Miyachi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yokoi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Togari</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Nakagawara</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants</article-title>
          <source>Cancer Lett.</source>
          <volume>164</volume>
          <year>2001</year>
          <fpage>51</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">11166915</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Newton</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Robb</surname>
              <given-names>G.B.</given-names>
            </name>
            <name>
              <surname>Kau</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>Cheung</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>VanDamme</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wilcox</surname>
              <given-names>J.N.</given-names>
            </name>
            <name>
              <surname>Marsden</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>RNA diversity has profound effects on the translation of neuronal nitric oxide synthase</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>96</volume>
          <year>1999</year>
          <fpage>12150</fpage>
          <lpage>12155</lpage>
          <pub-id pub-id-type="pmid">10518591</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pecci</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Viegas</surname>
              <given-names>L.R.</given-names>
            </name>
            <name>
              <surname>Baranao</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Beato</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene</article-title>
          <source>J. Biol. Chem.</source>
          <volume>276</volume>
          <year>2001</year>
          <fpage>21062</fpage>
          <lpage>21069</lpage>
          <pub-id pub-id-type="pmid">11274164</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murer</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Raisman-Vozari</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease</article-title>
          <source>Prog. Neurobiol.</source>
          <volume>63</volume>
          <year>2001</year>
          <fpage>71</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="pmid">11040419</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phillips</surname>
              <given-names>H.S.</given-names>
            </name>
            <name>
              <surname>Hains</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Armanini</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Laramee</surname>
              <given-names>G.R.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Winslow</surname>
              <given-names>J.W.</given-names>
            </name>
          </person-group>
          <article-title>BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease</article-title>
          <source>Neuron</source>
          <volume>7</volume>
          <year>1991</year>
          <fpage>695</fpage>
          <lpage>702</lpage>
          <pub-id pub-id-type="pmid">1742020</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Webster</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Weickert</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Herman</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Kleinman</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex</article-title>
          <source>Brain Res. Dev. Brain. Res.</source>
          <volume>139</volume>
          <year>2002</year>
          <fpage>139</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="pmid">12480128</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garzon</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Fahnestock</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex</article-title>
          <source>J. Neurochem.</source>
          <volume>82</volume>
          <year>2002</year>
          <fpage>1058</fpage>
          <lpage>1064</lpage>
          <pub-id pub-id-type="pmid">12358753</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ceccatelli</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ernfors</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Villar</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Persson</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hokfelt</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>88</volume>
          <year>1991</year>
          <fpage>10352</fpage>
          <lpage>10356</lpage>
          <pub-id pub-id-type="pmid">1946455</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hofer</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pagliusi</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Hohn</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Leibrock</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Barde</surname>
              <given-names>Y.A.</given-names>
            </name>
          </person-group>
          <article-title>Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain</article-title>
          <source>EMBO J.</source>
          <volume>9</volume>
          <year>1990</year>
          <fpage>2459</fpage>
          <lpage>2464</lpage>
          <pub-id pub-id-type="pmid">2369898</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Condorelli</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Dell'Albani</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Mudo</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Timmusk</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Belluardo</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Expression of neurotrophins and their receptors in primary astroglial cultures: induction by cyclic AMP-elevating agents</article-title>
          <source>J. Neurochem.</source>
          <volume>63</volume>
          <year>1994</year>
          <fpage>509</fpage>
          <lpage>516</lpage>
          <pub-id pub-id-type="pmid">7518499</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zafra</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Lindholm</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Castren</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Hartikka</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Thoenen</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes</article-title>
          <source>J. Neurosci.</source>
          <volume>12</volume>
          <year>1992</year>
          <fpage>4793</fpage>
          <lpage>4799</lpage>
          <pub-id pub-id-type="pmid">1281495</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elkabes</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>DiCicco-Bloom</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>I.B.</given-names>
            </name>
          </person-group>
          <article-title>Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function</article-title>
          <source>J. Neurosci.</source>
          <volume>16</volume>
          <year>1996</year>
          <fpage>2508</fpage>
          <lpage>2521</lpage>
          <pub-id pub-id-type="pmid">8786427</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dai</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Lercher</surname>
              <given-names>L.D.</given-names>
            </name>
            <name>
              <surname>Clinton</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Livingston</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Vieira</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Dreyfus</surname>
              <given-names>C.F.</given-names>
            </name>
          </person-group>
          <article-title>The trophic role of oligodendrocytes in the basal forebrain</article-title>
          <source>J. Neurosci.</source>
          <volume>23</volume>
          <year>2003</year>
          <fpage>5846</fpage>
          <lpage>5853</lpage>
          <pub-id pub-id-type="pmid">12843289</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Landry</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Mager</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Wilhelm</surname>
              <given-names>B.T.</given-names>
            </name>
          </person-group>
          <article-title>Complex controls: the role of alternative promoters in mammalian genomes</article-title>
          <source>Trends Genet.</source>
          <volume>19</volume>
          <year>2003</year>
          <fpage>640</fpage>
          <lpage>648</lpage>
          <pub-id pub-id-type="pmid">14585616</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lipscombe</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Neuronal proteins custom designed by alternative splicing</article-title>
          <source>Curr. Opin. Neurobiol.</source>
          <volume>15</volume>
          <year>2005</year>
          <fpage>358</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="pmid">15961039</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Korneev</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>O'Shea</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Natural antisense RNAs in the nervous system</article-title>
          <source>Rev. Neurosci.</source>
          <volume>16</volume>
          <year>2005</year>
          <fpage>213</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="pmid">16323561</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vanhee-Brossollet</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Vaquero</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Do natural antisense transcripts make sense in eukaryotes?</article-title>
          <source>Gene</source>
          <volume>211</volume>
          <year>1998</year>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">9573333</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alfano</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Vitiello</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Caccioppoli</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Caramico</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Carola</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Szego</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>McInnes</surname>
              <given-names>R.R.</given-names>
            </name>
            <name>
              <surname>Auricchio</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Banfi</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Natural antisense transcripts associated with genes involved in eye development</article-title>
          <source>Hum. Mol. Genet.</source>
          <volume>14</volume>
          <year>2005</year>
          <fpage>913</fpage>
          <lpage>923</lpage>
          <pub-id pub-id-type="pmid">15703187</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morey</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Avner</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Employment opportunities for non-coding RNAs</article-title>
          <source>FEBS Lett.</source>
          <volume>567</volume>
          <year>2004</year>
          <fpage>27</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">15165889</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borsani</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Verslues</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Sunkar</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J.K.</given-names>
            </name>
          </person-group>
          <article-title>Endogenous siRNAs derived from a pair of natural cis-antisense transcripts regulate salt tolerance in Arabidopsis</article-title>
          <source>Cell</source>
          <volume>123</volume>
          <year>2005</year>
          <fpage>1279</fpage>
          <lpage>1291</lpage>
          <pub-id pub-id-type="pmid">16377568</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marini</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Okagaki</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Lipsky</surname>
              <given-names>R.H.</given-names>
            </name>
          </person-group>
          <article-title>Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: from genes to phenotype</article-title>
          <source>Restor. Neurol. Neurosci.</source>
          <volume>22</volume>
          <year>2004</year>
          <fpage>121</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">15272146</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app1" sec-type="supplementary-material">
      <label>Appendix A</label>
      <title>Supplementary data</title>
      <p>
        <supplementary-material content-type="local-data" id="d32e1358">
          <caption>
            <title>Supplementary Table 1</title>
          </caption>
          <media xlink:href="mmc1.doc"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="d32e1363">
          <caption>
            <title>Supplementary Table 2</title>
          </caption>
          <media xlink:href="mmc2.doc"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="d32e1368">
          <caption>
            <title>Supplementary Legend</title>
          </caption>
          <media xlink:href="mmc3.doc"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="d32e1373">
          <caption>
            <title>Supplementary Figure 1</title>
          </caption>
          <media xlink:href="mmc4.pdf"/>
        </supplementary-material>
        <fig id="d32e1378" position="anchor">
          <label>Supplementary Figure 2</label>
          <graphic xlink:href="gr7"/>
        </fig>
      </p>
    </sec>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank Enn JÃµeste and Liina Kiho from North Estonian Regional Hospital, Tallinn, for help in collecting tissue samples; Epp VÃ¤li for technical assistance; Richard Tamme for critically reading the manuscript; and Mart Speek for experimental advice. This work was supported by the following grants to T.T.: Wellcome Trust International Senior Research Fellowship (Grant 067952) and Estonian Ministry of Education and Research (Grant 0222602).</p>
    </ack>
    <fn-group>
      <fn id="d32e192">
        <label>â</label>
        <p>Sequence data from this article have been deposited in the GenBank Data Libraries under Accession Nos. EF674517 - EF674521 and EF689009 - EF689021 (human <italic>BDNF</italic> mRNAs), and EF689022 - EF689042 (human <italic>antiBDNF</italic> RNAs).</p>
      </fn>
      <fn id="d32e1382" fn-type="supplementary-material">
        <label>Appendix A</label>
        <p>Supplementary data associated with this article can be found, in the online version, at <ext-link ext-link-type="doi" xlink:href="10.1016/j.ygeno.2007.05.004">doi:10.1016/j.ygeno.2007.05.004</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p>Structure and alternative transcripts of the human <italic>BDNF</italic> (top) and <italic>antiBDNF</italic> (bottom) genes. The structural organization of the exons and introns was determined by analyzing genomic and mRNA sequence data using bioinformatics, RT-PCR, and 5â² RACE. Exons are shown as boxes and introns as lines. Filled boxes and open boxes indicate the translated regions of the exons and the untranslated regions of the exons, respectively. The numbers below the exons and above the introns indicate their sizes. Exon and intron sizes are in base pairs, if not indicated otherwise. Arrows indicate the transcription start sites. ATG and TAG mark the positions of the translational start and stop codons, respectively. Vertical dashed lines indicate alternative splicing sites for the respective exons. <italic>BDNF</italic> exon IX is divided into regions âaâ, âbâ, âcâ, and âdâ as indicated in the box marking the position of exon IX. <italic>BDNF</italic> transcript names relate to the upstream exons used in front of the major 3â² exon IXd. âAâââLâ mark <italic>antiBDNF</italic> transcripts. Solid lines connecting the exons of transcripts represent the major splicing patterns of exons. Dashed lines connecting the exons of transcripts represent the minor splicing patterns of <italic>antiBDNF</italic>. Exon numbers are shown in Roman numerals for the <italic>BDNF</italic> gene and in Arabic numerals for the <italic>antiBDNF</italic> gene.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>(A) Comparison of the human and rodent <italic>BDNF</italic> gene structures proposed by different studies. Structures presented are according to Timmusk et al. <xref rid="bib15" ref-type="bibr">[15]</xref>, Liu et al. <xref rid="bib16" ref-type="bibr">[16]</xref>, Aid et al. <xref rid="bib17" ref-type="bibr">[17]</xref>, Aoyama et al. <xref rid="bib20" ref-type="bibr">[20]</xref>, Marini et al. <xref rid="bib40" ref-type="bibr">[40]</xref>, and Liu et al. <xref rid="bib19" ref-type="bibr">[19]</xref> and the human <italic>BDNF</italic> gene structure determined in this study. Exons are shown as boxes and introns as lines. The identical human exons and the rodent exons homologous to the human exons are shown in the same color in all the structures. Novel exons determined by this study are in green (V), red (Vh), purple (VIII), and light blue (VIIIh). (B) Amino acid sequences of different potential prepro-BDNF N-termini. Amino acids encoded by exon IX are in black and sequences encoded by alternative 5â² exons are in blue. The transcripts encoding the respective N-termini of BDNF are listed adjacent to the N-terminal sequences.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p>Semiquantitative analysis of human <italic>BDNF, antiBDNF,</italic> and control <italic>GAPDH</italic> mRNA expression in adult human tissues by RT-PCR. Roman numerals on the left indicate the detected <italic>BDNF</italic> transcripts and the 5â² exon-specific primers used in combination with an antisense primer located in the <italic>BDNF</italic> coding region in exon IXd (Supplementary Table 1). A, C, G, and I refer to the respective <italic>antiBDNF</italic> transcripts shown in <xref rid="fig1" ref-type="fig">Fig. 1</xref>.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Fig. 4</label>
      <caption>
        <p>Semiquantitative analysis of human <italic>BDNF, antiBDNF,</italic> and control <italic>GAPDH</italic> mRNA expression by RT-PCR in different human brain regions. Roman numerals on the left indicate the detected BDNF transcripts and the 5â²-exon-specific primers used in combination with an antisense primer located in the <italic>BDNF</italic> coding region in exon IXd (Supplementary Table 1). A, C, and G refer to the respective <italic>antiBDNF</italic> transcripts shown in <xref rid="fig1" ref-type="fig">Fig. 1</xref>.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig5">
      <label>Fig. 5</label>
      <caption>
        <p>Analyses of <italic>BDNF</italic> and <italic>antiBDNF</italic> promoter activities in HEK293T and N2a cells. The relative activities of the 5â² flanking regions of <italic>BDNF</italic> exons I, II, III, IV, V, Vh, VI, VII, and IXabcd and <italic>antiBDNF</italic> to promote CAT expression are shown. The promoter regions cloned in front of the <italic>CAT</italic> gene are shown in Supplementary Fig. 1. Note that the activities of <italic>BDNF</italic> promoters II, V, Vh, and VII in HEK239T cells were detectable using longer reaction times. m, mock-transfected cells, negative control.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="fig6">
      <label>Fig. 6</label>
      <caption>
        <p><italic>BDNF</italic> and <italic>antiBDNF</italic> transcripts form dsRNA duplexes in the human brain in vivo. A schematic representation of the RNA duplex detection assay is shown. Briefly, total human cerebellar RNA was DNase treated. This RNA was divided into twoâone half was treated with RNase A/T1 (box on the left) and the other was used as a âÂ RNase control (box on the right). Both RNAs were reverse transcribed (RT) with a <italic>BDNF</italic>/<italic>antiBDNF</italic> complementary region-specific primer, Dup_S1. Subsequently these cDNAs were used as templates in PCR to detect <italic>BDNF</italic>/<italic>antiBDNF</italic> duplex with primers Dup_S1 and Dup_AS. ssRNA contamination control reaction was conducted with primers Dup_S2 and haBDNF_S1. The âÂ RT reaction was used for detection of genomic DNA contamination using primers Dup_S1 and Dup_AS. Lines indicate RNAs, double line marks the complementary region of <italic>BDNF</italic> exon IXd and <italic>antiBDNF</italic> exon 5. Primer positions are indicated with arrows parallel with the lines and primer names are in italic. Human hippocampal cDNA synthesized using an oligo(dT) primer (PCRÂ +Â control) was used as positive control for all the reactions.</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>